Human coronaviruses: The emergence of SARS-CoV-2 and management of COVID-19-Reference-Cited by-同舟云学术

Human coronaviruses: The emergence of SARS-CoV-2 and management of COVID-19

Published:2022-10 Issue: Volume:319 Page:198882
ISSN:0168-1702
Container-title:Virus Research
language:en
Short-container-title:Virus Research

Author:

Solomon Magan,Liang Chen

Funder

Canadian Institutes of Health Research

Publisher

Elsevier BV

Subject

Cancer Research,Infectious Diseases,Virology

Reference126 articles.

1. Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial;Ader;Lancet Infect. Dis.,2021

2. Coronavirus susceptibility to the antiviral remdesivir (GS-5734) is mediated by the viral polymerase and the proofreading exoribonuclease;Agostini;mBio,2018

3. SARS-CoV-2 variants and their relevant mutational profiles: update summer 2021;Alkhatib;Microbiol. Spectr.,2021

4. Engineering the largest RNA virus genome as an infectious bacterial artificial chromosome;Almazán;Proc. Natl. Acad. Sci.,2000

5. Coronavirus reverse genetic systems: infectious clones and replicons;Almazán;Virus Res.,2014

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gene crosstalk between COVID-19 and preeclampsia revealed by blood transcriptome analysis;Frontiers in Immunology;2024-01-08

2. Microglia influence immune responses and restrict neurologic disease in response to central nervous system infection by a neurotropic murine coronavirus;Frontiers in Cellular Neuroscience;2023-11-30

3. COVID‐19 and the impact on Alzheimer's disease pathology;Journal of Neurochemistry;2023-10-18

4. Ebselen and Diphenyl Diselenide Inhibit SARS-CoV-2 Replication at Non-Toxic Concentrations to Human Cell Lines;Vaccines;2023-07-10

5. Identification of Histopathological Biomarkers in Fatal Cases of Coronavirus Disease: A Study on Lung Tissue;Diagnostics;2023-06-12